Skip to main content

CORRECTION article

Front. Immunol., 25 November 2022
Sec. Antigen Presenting Cell Biology
Volume 13 - 2022 | https://doi.org/10.3389/fimmu.2022.1094578
This article is part of the Research Topic Antigen Processing and Presentation in Autoimmunity View all 4 articles

Corrigendum: A novel type I interferon primed dendritic cell subpopulation in TREX1 mutant chilblain lupus patients

This article is a correction to:

  1. A Novel Type I Interferon Primed Dendritic Cell Subpopulation in TREX1 Mutant Chilblain Lupus Patients

    1. Read original article
Anne EugsterAnne Eugster1Denise MüllerDenise Müller1Anne GompfAnne Gompf1Susanne ReinhardtSusanne Reinhardt2Annett LindnerAnnett Lindner1Michelle AshtonMichelle Ashton1Nick ZimmermannNick Zimmermann3Stefan BeissertStefan Beissert3Ezio Bonifacio,Ezio Bonifacio1,4Claudia Günther*Claudia Günther3*
  • 1Center for Regenerative Therapies Dresden, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany
  • 2Center for Molecular and Cellular Bioengineering (CMCB), DRESDEN-Concept Genome Center, Technische Universität Dresden, Dresden, Germany
  • 3Department of Dermatology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
  • 4Faculty of Medicine, Paul Langerhans Institute Dresden of Helmholtz Centre Munich at University Clinic Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany

A Corrigendum on
A novel type I interferon primed dendritic cell subpopulation in TREX1 mutant chilblain lupus patients

by Eugster A, Müller D, Gompf A, Reinhardt S, Lindner A, Ashton M, Zimmermann N, Beissert S, Bonifacio E and Günther C (2022) 13:897500. doi: 10.3389/fimmu.2022.897500

In the published article, there was an error in affiliations 3 and 4. Instead of “[3 Faculty of Medicine, Paul Langerhans Institute Dresden of Helmholtz Centre Munich at University Clinic Carl Gustav Carus of Technische Universität (TU) Dresden, Dresden, Germany, 4 Department of Dermatology, Faculty of Medicine, University Hospital Carl Gustav Carus of Technische Universität (TU) Dresden, Dresden, Germany]”, it should be as shown above.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: monogenic familial chilblain lupus, SLE, Type I interferons, dendritic Cells (DC), LMNA, Lamin A/C, Trex1

Citation: Eugster A, Müller D, Gompf A, Reinhardt S, Lindner A, Ashton M, Zimmermann N, Beissert S, Bonifacio E and Günther C (2022) Corrigendum: A novel type I interferon primed dendritic cell subpopulation in TREX1 mutant chilblain lupus patients. Front. Immunol. 13:1094578. doi: 10.3389/fimmu.2022.1094578

Received: 10 November 2022; Accepted: 18 November 2022;
Published: 25 November 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Eugster, Müller, Gompf, Reinhardt, Lindner, Ashton, Zimmermann, Beissert, Bonifacio and Günther. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Claudia Günther, Q2xhdWRpYS5HdWVudGhlckB1a2RkLmRl

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.